Advertisement
Screener

PRECIPIO, INC. (PRPO) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

PRECIPIO, INC. Research and Development Expense

PRECIPIO, INC. (PRPO) reported Research and Development Expense of $1.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-30

  • PRECIPIO, INC. research and development expense for the quarter ending 2017-03-31 was $134.00K, a 50.37% decline year-over-year.
  • PRECIPIO, INC. research and development expense for the quarter ending 2016-12-31 was -$1.06M, a 322.34% decline year-over-year.
  • PRECIPIO, INC. research and development expense for the quarter ending 2016-09-30 was $393.00K, a 13.63% decline year-over-year.
  • PRECIPIO, INC. research and development expense for the quarter ending 2016-06-30 was $402.00K, a 14.10% decline year-over-year.
  • PRECIPIO, INC. research and development expense for fiscal 2025 was $1.60M, a 23.08% increase from fiscal 2024.
  • PRECIPIO, INC. research and development expense for fiscal 2024 was $1.30M, a 23.53% decline from fiscal 2023.
  • PRECIPIO, INC. research and development expense for fiscal 2023 was $1.70M, a 0.00% change from fiscal 2022.
  • PRECIPIO, INC. research and development expense for fiscal 2022 was $1.70M, a 30.77% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2025-12-31$1.60M
10-K · filed 2026-03-30
2024-12-31$1.30M
10-K · filed 2026-03-30
2023-12-31$1.70M
10-K · filed 2025-03-27
2022-12-31$1.70M
10-K · filed 2024-03-29
2021-12-31$1.30M
10-K · filed 2023-03-30
2020-12-31$1.20M
10-K · filed 2022-03-30
2019-12-31$1.20M
10-K · filed 2020-03-27
2018-12-31$1.10M
10-K · filed 2020-03-27
2017-12-31$500.00K
10-K · filed 2019-04-16
2017-03-31$134.00K
10-Q · filed 2017-05-18
-$931.00K
derived: sum of 2 quarters · filed 2018-04-13
-$538.00K
derived: sum of 3 quarters · filed 2018-04-13
-$136.00K
derived: sum of 4 quarters · filed 2018-04-13
2016-12-31-$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-13
-$672.00K
derived: sum of 2 quarters · filed 2018-04-13
-$270.00K
derived: sum of 3 quarters · filed 2018-04-13
$0.00
10-K · filed 2018-04-13
$1.42M
10-K · filed 2017-04-13
2016-09-30$393.00K
10-Q · filed 2016-11-14
$795.00K
derived: sum of 2 quarters · filed 2016-11-14
$1.06M
10-Q · filed 2016-11-14
$1.54M
derived: sum of 4 quarters · filed 2017-05-18
2016-06-30$402.00K
10-Q · filed 2016-08-15
$672.00K
10-Q · filed 2016-08-15
$1.15M
derived: sum of 3 quarters · filed 2017-05-18
$1.61M
derived: sum of 4 quarters · filed 2017-05-18
2016-03-31$270.00K
10-Q · filed 2017-05-18
$749.00K
derived: sum of 2 quarters · filed 2017-05-18
$1.20M
derived: sum of 3 quarters · filed 2017-05-18
$1.67M
derived: sum of 4 quarters · filed 2017-05-18
2015-12-31$479.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13
$934.00K
derived: sum of 2 quarters · filed 2017-04-13
$1.40M
derived: sum of 3 quarters · filed 2017-04-13
$1.85M
10-K · filed 2017-04-13
2015-09-30$455.00K
10-Q · filed 2016-11-14
$561.00K
10-Q · filed 2015-11-16
$923.00K
derived: sum of 2 quarters · filed 2016-11-14
$1.37M
10-Q · filed 2016-11-14
$1.70M
10-Q · filed 2015-11-16
$1.45M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$468.00K
10-Q · filed 2016-08-15
$576.00K
10-Q · filed 2015-08-14
$919.00K
10-Q · filed 2016-08-15
$1.14M
10-Q · filed 2015-08-14
$997.00K
derived: sum of 3 quarters · filed 2016-08-15
$1.64M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$451.00K
10-Q · filed 2016-05-23
$567.00K
10-Q · filed 2015-05-14
$529.00K
derived: sum of 2 quarters · filed 2016-05-23
$1.17M
derived: sum of 3 quarters · filed 2016-05-23
$1.96M
derived: sum of 4 quarters · filed 2016-05-23
2014-12-31$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14
$719.00K
derived: sum of 2 quarters · filed 2016-04-14
$1.50M
derived: sum of 3 quarters · filed 2016-04-14
$2.25M
10-K · filed 2016-04-14
$2.90M
10-K · filed 2015-04-15
2014-09-30$641.00K
10-Q · filed 2015-11-16
$1.43M
derived: sum of 2 quarters · filed 2015-11-16
$2.17M
10-Q · filed 2015-11-16
$3.08M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$785.00K
10-Q · filed 2015-08-14
$1.53M
10-Q · filed 2015-08-14
$2.44M
derived: sum of 3 quarters · filed 2015-08-14
$3.06M
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31$745.00K
10-Q · filed 2015-05-14
$1.65M
derived: sum of 2 quarters · filed 2015-05-14
$2.28M
derived: sum of 3 quarters · filed 2015-05-14
$3.19M
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31$905.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15
$1.53M
derived: sum of 2 quarters · filed 2015-04-15
$2.45M
derived: sum of 3 quarters · filed 2015-04-15
$3.21M
10-K · filed 2015-04-15
2013-09-30$630.00K
10-Q · filed 2014-11-12
$1.54M
derived: sum of 2 quarters · filed 2014-11-12
$2.31M
10-Q · filed 2014-11-12
$2.93M
derived: sum of 4 quarters · filed 2015-04-15
2013-06-30$913.00K
10-Q · filed 2014-08-08
$1.68M
10-Q · filed 2014-08-08
$2.30M
derived: sum of 3 quarters · filed 2015-04-15
$2.97M
derived: sum of 4 quarters · filed 2015-04-15
2013-03-31$764.00K
10-Q · filed 2014-05-15
$1.39M
derived: sum of 2 quarters · filed 2015-04-15
$2.05M
derived: sum of 3 quarters · filed 2015-04-15
$2.71M
derived: sum of 4 quarters · filed 2015-04-15
2012-12-31$621.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15
$1.29M
derived: sum of 2 quarters · filed 2015-04-15
$1.94M
derived: sum of 3 quarters · filed 2015-04-15
$2.49M
10-K · filed 2015-04-15
2012-09-30$668.00K
10-Q · filed 2013-11-14
$1.32M
derived: sum of 2 quarters · filed 2013-11-14
$1.87M
10-Q · filed 2013-11-14
$2.44M
derived: sum of 4 quarters · filed 2014-03-27
2012-06-30$654.00K
10-Q · filed 2013-08-08
$1.20M
10-Q · filed 2013-08-08
$1.77M
derived: sum of 3 quarters · filed 2014-03-27
$2.29M
derived: sum of 4 quarters · filed 2014-03-27
2012-03-31$549.00K
10-Q · filed 2013-05-09
$1.12M
derived: sum of 2 quarters · filed 2014-03-27
$1.63M
derived: sum of 3 quarters · filed 2014-03-27
$2.21M
derived: sum of 4 quarters · filed 2014-03-27
2011-12-31$568.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
$1.08M
derived: sum of 2 quarters · filed 2014-03-27
$1.66M
derived: sum of 3 quarters · filed 2014-03-27
$2.22M
10-K · filed 2014-03-27
2011-09-30$515.00K
10-Q · filed 2012-11-08
$1.09M
derived: sum of 2 quarters · filed 2012-11-08
$1.65M
10-Q · filed 2012-11-08
$2.00M
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30$579.00K
10-Q · filed 2012-08-02
$1.14M
10-Q · filed 2012-08-02
$1.49M
derived: sum of 3 quarters · filed 2013-03-14
$2.10M
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31$557.00K
10-Q · filed 2012-05-09
$910.00K
derived: sum of 2 quarters · filed 2013-03-14
$1.52M
derived: sum of 3 quarters · filed 2013-03-14
$2.04M
derived: sum of 4 quarters · filed 2013-03-14
2010-12-31$353.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
$966.00K
derived: sum of 2 quarters · filed 2013-03-14
$1.48M
derived: sum of 3 quarters · filed 2013-03-14
$2.31M
10-K · filed 2013-03-14
2010-09-30$613.00K
10-Q · filed 2011-11-10
$1.13M
derived: sum of 2 quarters · filed 2011-11-10
$1.95M
10-Q · filed 2011-11-10
2010-06-30$512.00K
10-Q · filed 2011-08-12
$1.34M
10-Q · filed 2011-08-12
2009-12-31$3.18M
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15